You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 16, 2024

CLINICAL TRIALS PROFILE FOR QUILLIVANT XR

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for QUILLIVANT XR

Subscribe to access the full database, or Try a Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00904670 ↗	Quillivant Oral Suspension (Quillivant XR) in the Treatment of Attention Deficit Hyperactivity Disorder (ADHD)	Completed	Pfizer	Phase 3	2009-04-01	The objective of this study was to establish that an optimal dose of Quillivant XR oral suspension would result in a significant reduction in signs and symptoms of ADHD compared to placebo treatment in pediatric patients ages 6-12 years with ADHD.
NCT02255565 ↗	Dose Response Effects of Quillivant XR in Children With ADHD and Autism: A Pilot Study	Completed	Pfizer	Phase 4	2014-09-01	The purpose of this study is to determine whether Quillivant XR is effective in the treatment of ADHD in children with Autism Spectrum Disorder (ASD).
NCT02255565 ↗	Dose Response Effects of Quillivant XR in Children With ADHD and Autism: A Pilot Study	Completed	Seattle Children's Hospital	Phase 4	2014-09-01	The purpose of this study is to determine whether Quillivant XR is effective in the treatment of ADHD in children with Autism Spectrum Disorder (ASD).
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for QUILLIVANT XR

Condition Name

Chart
Table

Condition Name for QUILLIVANT XR
Intervention	Trials
Attention Deficit Hyperactivity Disorder	3
ADHD	1
Autism	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for QUILLIVANT XR
Intervention	Trials
Attention Deficit Disorder with Hyperactivity	4
Syndrome	1
Disease	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for QUILLIVANT XR

Trials by Country

Map
Table

Trials by Country for QUILLIVANT XR
Location	Trials
United States	4
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for QUILLIVANT XR
Location	Trials
Iowa	1
Washington	1
Nevada	1
California	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for QUILLIVANT XR

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for QUILLIVANT XR
Clinical Trial Phase	Trials
Phase 4	2
Phase 3	1
Phase 1	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for QUILLIVANT XR
Clinical Trial Phase	Trials
Completed	2
Recruiting	1
Not yet recruiting	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for QUILLIVANT XR

Sponsor Name

Chart
Table

Sponsor Name for QUILLIVANT XR
Sponsor	Trials
Pfizer	2
Seattle Children's Hospital	1
Matthew J O'Brien, PhD, BCBA-D	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for QUILLIVANT XR
Sponsor	Trials
Other	4
Industry	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.